Documentation Centre

October 07, 2021
Inhibiting interleukin-6 to reduce cardiovascular event rates: A next step for atherothrombosis treatment and prevention. J Am Coll Cardiol. 2021;77:1856-1858
Ridker PM

Description of this Publication

Consult publication on external website

By clicking on this link, you will leave the INTERNATIONAL CHAIR ON CARDIOMETABOLIC RISK website

Key Words
Cardiovascular Disease, Clinical Trials, Inflammation